Developmental differences between newborn and adult mice in response to romiplostim

Platelets

Volumn 29, Issue 4, 2018, Pages 365-372

  Sparger, Katherine A ^a,b   Ramsey, Haley ^a   Lorenz, Viola ^a   Liu, Zhi Jian ^a   Feldman, Henry A ^a   Li, Nan ^a   Laforest, Tahirih ^a   Sola Visner, Martha C ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Immature platelet fraction (IPF); newborn; thrombocytopenia; thrombopoietin mimetic

Indexed keywords

ROMIPLOSTIM; THROMBOPOIETIN; FC RECEPTOR; FUSION PROTEIN;

ADULT; AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL SIZE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE INCREASE; HEMATOPOIETIC STEM CELL; IMMATURE PLATELET FRACTION; IN VITRO STUDY; IN VIVO STUDY; LIVER; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MOUSE; NEWBORN; NONHUMAN; PLATELET COUNT; PRIORITY JOURNAL; SINGLE DRUG DOSE; SPLEEN; THROMBOCYTE; THROMBOCYTOPOIESIS; ANIMAL; HUMAN; MALE; THROMBOCYTOPENIA;

ADULT; ANIMALS; HUMANS; INFANT, NEWBORN; MALE; MICE; RECEPTORS, FC; RECOMBINANT FUSION PROTEINS; THROMBOCYTOPENIA; THROMBOPOIETIN;

EID: 85019676279     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537104.2017.1316481     Document Type: Article

References (29)

1. Andrew M, Castle V, Saigal S, Carter C, Kelton JG., Clinical impact of neonatal thrombocytopenia. J Pediatr 1987;110:457–464.
2. Castle V, Andrew M, Kelton J, Giron D, Johnston M, Carter C., Frequency and mechanism of neonatal thrombocytopenia. J Pediatr 1986;108:749–755.
3. Mehta P, Vasa R, Neumann L, Karpatkin M., Thrombocytopenia in the high-risk infant. J Pediatr 1980;97:791–794.
4. Christensen RD, Henry E, Wiedmeier SE, et al. Thrombocytopenia among extremely low birth weight neonates: data from a multihospital healthcare system. J Perinatol Off J California Perinatal Assoc 2006;26:348–353.
5. Murray NA, Roberts IA., Circulating megakaryocytes and their progenitors in early thrombocytopenia in preterm neonates. Pediatr Res 1996;40:112–119.
6. Sola MC, Calhoun DA, Hutson AD, Christensen RD., Plasma thrombopoietin concentrations in thrombocytopenic and non-thrombocytopenic patients in a Neonatal Intensive Care Unit. Br J Haematol 1999;104:90–92.
7. Liu ZJ, Bussel JB, Lakkaraja M, et al. Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodies. Blood 2015;126:1234–1236.
8. Warwick RM, Vaughan J, Murray N, Lubenko A, Roberts I., In vitro culture of colony forming unit-megakaryocyte (CFU-MK) in fetal alloimmune thrombocytopenia. Br J Haematol 1994;88:874–877.
9. Cremer M, Weimann A, Szekessy D, Hammer H, Buhrer C, Dame C., Low immature platelet fraction suggests decreased megakaryopoiesis in neonates with sepsis or necrotizing enterocolitis. J Perinatol Off J California Perinatal Assoc 2013;33:622–626.
10. Brown RE, Rimsza LM, Pastos K, et al. Effects of sepsis on neonatal thrombopoiesis. Pediatr Res 2008;64(4):399–404.
11. Del Vecchio A, Sola MC, Theriaque DW, et al. Platelet transfusions in the Neonatal Intensive Care Unit: factorspredicting which patients will require multiple transfusions. Transfusion 2001;41:803–808.
12. Dohner ML, Wiedmeier SE, Stoddard RA, et al. Very high users of platelet transfusions in the Neonatal Intensive Care Unit. Transfusion 2009;49:869–872.
13. Christensen RD, Baer VL, Henry E, Snow GL, Butler A, Sola-Visner MC., Thrombocytopenia in small-for-gestational-age infants. Pediatrics 2015;136:e361–70.
14. Christensen RD, Yaish HM, Leon EL, Sola-Visner MC, Agrawal PB., A de novo T73I Mutation in PTPN11 in a neonate with severe and prolonged congenital thrombocytopenia and noonan syndrome. Neonatology 2013;104:1–5.
15. Sola MC, Du Y, Hutson AD, Christensen RD., Dose-response relationship of megakaryocyte progenitors from the bone marrow of thrombocytopenic and non-thrombocytopenic neonates to recombinant thrombopoietin. Br J Haematol 2000;110:449–453.
16. Pastos KM, Slayton WB, Rimsza LM, Young L, Sola-Visner MC., Differential effects of recombinant thrombopoietin and bone marrow stromal-conditioned media on neonatal versus adult megakaryocytes. Blood 2006;108:3360–3362.
17. Liu ZJ, Italiano J, Jr., Ferrer-Marin F, et al. Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes. Blood 2011;117:4106–4117.
18. Hu Z, Slayton WB, Rimsza LM, Bailey M, Sallmon H, Sola-Visner MC., Differences between newborn and adult mice in their response to immune thrombocytopenia. Neonatology 2010;98:100–108.
19. Murray NA, Watts TL, Roberts IA., Endogenous thrombopoietin levels and effect of recombinant human thrombopoietin on megakaryocyte precursors in term and preterm babies. Pediatr Res 1998;43:148–151.
20. Sola MC, Juul SE, Meng YG, et al. Thrombopoietin (Tpo) in the fetus and neonate: tpo concentrations in preterm and term neonates, and organ distribution of Tpo and its receptor (c-mpl) during human fetal development. Early Hum Dev 1999;53:239–250.
21. Dame C., Developmental biology of thrombopoietin in the human fetus and neonate. Acta Paediatr Suppl 2002;91:54–65.
22. Wolber EM, Dame C, Fahnenstich H, et al. Expression of the thrombopoietin gene in human fetal and neonatal tissues. Blood 1999;94:97–105.
23. Liu ZJ, Hoffmeister KM, Hu Z, et al. Expansion of the neonatal platelet mass is achieved via an extension of platelet lifespan. Blood 2014;123:3381–3389.
24. Sola-Visner MC, Christensen RD, Hutson AD, Rimsza LM., Megakaryocyte size and concentration in the bone marrow of thrombocytopenic and nonthrombocytopenic neonates. Pediatr Res 2007;61:479–484.
25. Currao M, Balduini CL, Balduini A., High doses of romiplostim induce proliferation and reduce proplatelet formation by human megakaryocytes. Plos One 2013;8:e54723.
26. Fuchs DA, McGinn SG, Cantu CL, Klein RR, Sola-Visner MC, Rimsza LM., Developmental differences in megakaryocyte size in infants and children. Am J Clin Pathol 2012;138:140–145.
27. Cremer M, Paetzold J, Schmalisch G, et al. Immature platelet fraction as novel laboratory parameter predicting the course of neonatal thrombocytopenia. Br J Haematol 2009;144:619–621.
28. Sokolic R, Oden N, Candotti F., Assessment of immature platelet fraction in the diagnosis of Wiskott-Aldrich Syndrome. Front Pediatr 2015;3:49.
29. Tarantino MD, Bussel JB, Blanchette VS, et al. Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study. Lancet 2016;388(10039):45–54.